BioCentury
ARTICLE | Cover Story

Navigating the new road in psychiatry

August 14, 2014 7:00 AM UTC

The lack of predictive animal models for neuropsychiatric diseases is arguably the biggest single factor stifling drug development in the field. To kick-start discovery for diseases such as autism, schizophrenia and depression, stakeholders will need to abandon traditional models, build on emerging genetic findings and capitalize on new capabilities in stem cell technology, imaging and computational modeling.

Ultimately, drug developers will need to come together in precompetitive consortia, share data and find consensus for new standards, techniques and models...